UPDATE 1-Chelsea Therapeutics fibromyalgia drug shows promise

Dec 22 (Reuters) - Chelsea Therapeutics International Ltd said a mid-stage trial of its experimental fibromyalgia drug showed the highest dose of the drug was more effective in reducing pain, compared with a placebo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.